Clinical Trials

115 enrolled

Bladder Urothelial Cancer

NCT04149691 2024-02-07

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

GastrointestinalGenitourinaryGynecologicSarcoma

42 enrolled

Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT04943380 2024-02-02

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

684 enrolled

Carcinoma, Transitional Cell, Hematuria

NCT05861947 2024-01-31

JIVAN

GastrointestinalGenitourinaryThoracic

30 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Recurrence, Stomach Neoplasms

NCT06222125 2024-01-24

A Study of HB0025 Injection in Patients With Advanced Renal Cancer

100 enrolled

Kidney Neoplasms

NCT05732948 2023-11-29

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

12 enrolled

Prostatic Neoplasms

NCT05580107 2023-11-07

MDPK67b in Patients With Prostate Cancer

15 enrolled

Prostatic Neoplasms

NCT04097002 2023-10-31

First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.

Adenoviridae Infections, Prostatic Neoplasms

NCT04155359 2023-10-25

Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients

444 enrolled

Urinary Bladder Neoplasms

NCT04661176 2023-10-25

Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico

500 enrolled

Disease, Prostatic Neoplasms

NCT06011304 2023-10-23

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Phase 3 Unknown

267 enrolled

Prostatic Neoplasms

NCT06062355 2023-10-02

Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer

9 enrolled

Prostatic Neoplasms

NCT06049030 2023-09-26

A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma

190 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06034015 2023-09-13

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers

48 enrolled

Urinary Bladder Neoplasms

NCT06006104 2023-08-23

Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer

49 enrolled

Advanced Prostate Cancer

NCT05420519 2023-08-18

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT05420545 2023-08-18

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

36 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05468190 2023-08-18

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

48 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT03961698 2023-08-14

MARIO-3

91 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT05422105 2023-08-07

Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient

230 enrolled

Prostatic Neoplasms

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

314 enrolled

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT05223218 2023-07-03

Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

BreastDermatologicGastrointestinalGenitourinaryGynecologic

500 enrolled

Breast Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT05823246 2023-05-26

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

DermatologicGenitourinary

66 enrolled

Carcinoma, Transitional Cell, Melanoma

NCT04240639 2023-05-18

An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue

60 enrolled

Neoplasms of the Prostate

NCT05607693 2023-05-15

A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

52 enrolled

Castration-Resistant Prostate Cancer

NCT05856630 2023-05-12

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

Prostatic Neoplasms

NCT05843305 2023-05-06

A Study of BPI-452080 in Subjects With Solid Tumors

87 enrolled

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT05633342 2023-03-20

CADENCE

BreastGastrointestinalGenitourinaryGynecologic

15,000 enrolled

Breast Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05775874 2023-03-20

A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC

80 enrolled

Carcinoma, Transitional Cell

NCT04565275 2023-03-14

A Study of ICP-192 in Patients With Advanced Solid Tumors

GastrointestinalGenitourinary

45 enrolled

Carcinoma, Transitional Cell, Cholangiocarcinoma

NCT04768868 2023-02-24

WEE1

BreastGastrointestinalGenitourinaryGynecologic

350 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT04799847 2023-02-13

Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine

161 enrolled

Urinary Bladder Neoplasms

NCT01972867 2023-02-01

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

6 enrolled

Neoplasms, Prostatic Neoplasms

NCT05508568 2023-02-01

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

650 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05700370 2023-01-26

MyProstateScore Equivalency With and Without DRE

800 enrolled

Neoplasms, Prostatic Neoplasms

NCT05533203 2023-01-23

Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Cancer

NCT05685524 2023-01-17

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

3,000 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05227898 2022-10-25

RESTORE

BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmThoracic

352 enrolled

Breast Neoplasms, Colonic Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT05572099 2022-10-07

ExoDx Prostate Evaluation in Active Surveillance Patient Population

750 enrolled

Prostatic Neoplasms

NCT03634982 2022-09-01

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

133 enrolled

Urinary Bladder Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Noonan Syndrome, Ovarian Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Skin Neoplasms, Thoracic Neoplasms, Uterine Neoplasms, Neoplasms, Squamous Cell

NCT05440045 2022-08-17

A Clinical Study of 6MW3211 in Patients With Renal Cancer

30 enrolled

Phase EARLY_PHASE1 Unknown

Advanced Clear Cell Renal Cell Carcinoma

NCT03692663 2022-08-01

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

9 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT04108247 2022-07-07

A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC

39 enrolled

Prostate Cancer Castration-resistant Prostate Cancer

NCT03827837 2022-07-01

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

265 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03235687 2022-05-06

Decision Impact Trial of the ExoDx Prostate (IntelliScore)

1,000 enrolled

Prostatic Neoplasms

NCT04819399 2022-04-05

Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC

30 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04490993 2022-02-22

ACCRUE

Phase 3 Unknown

359 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04736394 2022-02-22

ASCERTAIN

Phase 3 Unknown

800 enrolled